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Phosphate carrierCarbon monoxide is continuously produced in small quantities in tissues and is an important signaling mediator
in mammalian cells. We previously demonstrated that CO delivered to isolated rat heart mitochondria using a
water-soluble CO-releasing molecule (CORM-3) is able to uncouple mitochondrial respiration. The aim of this
study was to explore more in depth the mechanism(s) of this uncoupling effect. We found that acceleration of
mitochondrial O2 consumption and decrease in membrane potential induced by CORM-3 were associated with
an increase inmitochondrial swelling. This effect was independent of the opening of themitochondrial transition
pore as cyclosporineAwas unable to prevent it. Interestingly, removal of phosphate from the incubationmedium
suppressed the effects mediated by CORM-3. Blockade of the dicarboxylate carrier, which exchanges
dicarboxylate for phosphate, decreased the effects induced by CORM-3 while direct inhibition of the phosphate
carrier with N-ethylmaleimide completely abolished the effects of CORM-3. In addition, CORM-3 was able to
enhance the transport of phosphate into mitochondria as evidenced by changes in mitochondrial phosphate
concentration and mitochondrial swelling that evaluates the activity of the phosphate carrier in de-energized
conditions. These results indicate that CORM-3 activates the phosphate carrier leading to an increase in
phosphate and proton transport inside mitochondria, both of which could contribute to the non-classical
uncoupling effect mediated by CORM-3. The dicarboxylate carrier ampliﬁes this effect by increasing intra-
mitochondrial phosphate concentration.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
Carbonmonoxide (CO) is well-known for its poisonous effects when
inhaled at high concentrations and for prolonged times in eukaryotic
organisms. Its high afﬁnity for heme makes it a powerful competitor
of molecular oxygen (O2) at the level of both hemoglobin and
mitochondrial cytochrome c oxidase, which are essential for O2 supply
and cellular respiration, respectively. The toxic properties of CO
are counterbalanced by its intrinsic cell signaling function since CO
is continuously produced in small quantities in tissues, regulates
several physiological processes and exerts beneﬁcial effects against
pathophysiological conditions [1–3]. Corroborating data obtained using
preclinical models of diseases showed that administration of low dosesreleasing molecules; CORM-3,
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ights reserved.of CO in its gaseous form mitigates the progression of vascular and
inﬂammatory pathologies affecting the cardiovascular and nervous
systems [3,4]. Because the delivery of accurate doses of CO to the selected
molecular target by direct gas inhalation remains difﬁcult to achieve,
CO-releasing molecules (CO-RMs) have been developed as a promising
alternative technology. This class of compounds is primarily based on
transition metal carbonyls that are able to store the gas in a stable
chemical form and thus deliver controlled amounts of CO to biological
systems [3]. Different CO-RMs have been tested in a number of in vitro
and in vivo models demonstrating the vasodilatory, anti-inﬂammatory
and anti-ischemic effects of CO [3,5–7].
Recent data revealed that mitochondria might be important targets
in transducing the beneﬁcial effects of CO. For instance, it has been
reported that the protective effects of CO gas and CO-RMs against
cardiomyopathy and cardiac dysfunction in sepsis, respectively, are
mediated by increased mitochondrial biogenesis [8,9]. These data
have been reinforced by our recent observation showing that low-
micromolar concentrations of CO delivered to isolated rat heart
mitochondria by CORM-3 promote a mild uncoupling effect resulting
in increased basal respiration and decreased mitochondrial membrane
potential in the absence of ADP. These effects were inhibited by
malonate suggesting a partial role for complex II of the respiratory
chain in the uncoupling effect mediated by CO [10]. The purpose of
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by which low concentrations of CORM-3 uncouple mitochondrial
respiration.
2. Material and methods
2.1. Animals
Animal procedures used in this studywere conducted in accordance
with the Directives of the European Parliament (2010/63/EU-848 EEC)
and recommendations of the French Ministère de l'Agriculture. Male
Wistar rats, weighting 250 to 300 g (7–8 weeks), were purchased
from Janvier (Le Genest-St-Isle, France). They were housed in a room
maintained under constant environmental conditions (temperature
of 22–25 °C and a constant cycle of 12-h light/dark). They were
acclimatized to the animal room before being used and received
standard rat diet and water ad libitum.
2.2. Reagents
Ru(CO)3Cl(glycinate) (CORM-3) was synthesized as previously
described [6]. Depleted inactive CORM-3 (iCORM-3), which does not
release CO to myoglobin, was also prepared as previously described by
placing CORM-3 in phosphate buffer solution for 2 days and then
bubbling the solution with N2 gas to remove the residual solubilized
CO [6]. Deoxygenated myoglobin (20 μM) prepared as previously
described [10] was used as CO scavenger. 2′,7′-bis-(2-carboxyethyl)-5-
(and-6)-carboxyﬂuorescein (BCECF-AM) was obtained from Invitrogen
(Cergy-Pontoise, France). All other reagents were purchased from
Sigma (Saint-Quentin Fallavier, France).
2.3. Isolation of mitochondria from rat heart
MaleWistar rats (250–300g, Janvier, Le Genest-St-Isle, France)were
used for the preparation of heart mitochondria as described before [11].
Brieﬂy, heartswere initially homogenized for 5s in a cold buffer solution
(220 mM mannitol, 70 mM sucrose, 10 mM HEPES, 2 mM EGTA,
pH 7.4 at 4 °C), using a Polytron homogenizer. Samples were then
further homogenized for ﬁve consecutive times in a Potter-Elvehjem
glass homogenizer at 1500 rpm. The homogenate was centrifuged at
1000 g for 5 min at 4 °C. The supernatant was centrifuged at 10000 g
for 10 min at 4 °C. The mitochondrial pellet was resuspended in
homogenization buffer without EGTA and protein concentration was
determined using the “Advanced protein assay reagent” (Sigma, catalog
number 57697).
2.4. Measurement of mitochondrial respiration
O2 consumption was measured by a Clark-type oxygen micro-
electrode ﬁtted to a water-jacketed reaction chamber (Hansatech,
Cergy, France) as described before [12]. Mitochondria (0.4 mg/mL
protein) were incubated in a respiration buffer containing 100 mM
KCl, 50 mM sucrose, 10 mM HEPES, 5 mM KH2PO4, pH 7.4 at 30 °C.
Mitochondrial respiration (state 2) was initiated by addition of
pyruvate/malate (5 mM each) and after 1 min CORM-3 (20 μM) or
iCORM-3 was added to the medium.
2.5. Measurement of mitochondrial membrane potential
Mitochondrial membrane potential (Ψm) was evaluated by the
uptake of the ﬂuorescent dye rhodamine 123, which accumulates
electrophoretically into energized mitochondria in response to their
negative inner-membrane potential. Rhodamine 123 (0.2 μM) and the
respiratory substrates pyruvate/malatewere added to respiration buffer
contained in a cuvettemaintained at 30°C. Fluorescencewasmonitored
over time using a PerkinElmer SA LS 50B (excitation wavelength =503 nm; emission wavelength = 527 nm). After 20 s of recording,
mitochondria (0.4mg/mL) were added in the cuvette and the effect of
CORM-3 or iCORM-3 on the membrane potential was examined after
addition of the compounds at 120 s. Tyrphostine A9 (1 μM) was added
at the end of the experiment to depolarize mitochondrial membrane
potential.
2.6. Mitochondrial swelling assays
The effect of CORM-3 on mitochondrial swelling was assessed
by measuring the change in absorbance at 540nm (A540) using a Jasco
V-530 spectrophotometer. Experiments were carried out at 30 °C in
the respiration buffer. Mitochondria (0.4 mg/mL) were incubated in
the presence of various substrates (5 mM each; pyruvate, malate,
glutamate, succinate or a combination of these substrates) for 50 s and
swelling was induced by addition of increasing concentrations of
CORM-3. When inhibitors were used, they were introduced at the
beginning of the incubation period.
2.7. Phosphate transport assays
Two complementary methods were used for the measurement of
phosphate transport in mitochondria. First, phosphate transport
was evaluated by a swelling assay in de-energized conditions as
previously described [13], by measuring the change in absorbance
at 540 nm (A540) using a Jasco V-530 spectrophotometer.
Mitochondria (0.4 mg/mL) were incubated at 30 °C in KCl buffer
(125mM KCl, 20mMMOPS, 10mM Tris, 0.5mM EGTA, 4 μM nigericin,
0.5 μM rotenone, 0.5 μM antimycin A, pH 7.2) in the presence of
40mM KH2PO4 to initiate phosphate transport and 1 μM cyclosporine
A to prevent mPTP opening. CORM-3 was added after 50s.
Secondly, phosphate transport was assessed by direct measurements
of mitochondrial phosphate concentration. Mitochondria (0.4 mg/mL
protein) were incubated in the respiration buffer in the presence of
pyruvate/malate (5 mM each). After 2min, CORM-3 (10, 20 or 40 μM)
or iCORM-3 was added to the medium and the incubation was followed
for 0.25, 0.5, 1, 2, 5 or 10min. At each time point, mitochondria were put
on ice and immediately centrifuged at 13000 g for 10 min at 4 °C. The
pellet containing mitochondria was resuspended in 1mL of water and
was subjected to three cycles of freezing/thawing (10 min at −80 °C/
5min at 30 °C) and inorganic phosphate concentration was determined
according to the green malachite method [14]. Results are reported in
nmol/mg proteins.
2.8. Measurement of intra-mitochondrial pH
Intra-mitochondrial pH (pHi) was evaluated using the non-
ﬂuorescent probe BCECF-AM, which is converted to ﬂuorescent BCECF
via the action of esterases. BCECFﬂuorescence is pH-dependent. Isolated
mitochondria were loaded with BCECF-AM (30 μM) for 1 h at 4 °C.
Mitochondria were then washed in 15mL homogenization buffer and
after centrifugation (10 min, 10000 g) the pellet was resuspended in
200 μL homogenization buffer. Loaded mitochondria (0.4 mg/mL)
were incubated in the respiration buffer (1 mL) maintained at 30 °C
under constant agitation and ﬂuorescence was followed using a
temperature-controlled spectroﬂuorometer (Jasco FP-6300, excitation
wavelength = 488 nm; emission wavelength = 525 nm). After 30 s,
various substrates were introduced and then iCORM-3, tyrphostine A9
(1 μM) or increasing concentrations of CORM-3 were added. At the
end of the experiment, tyrphostine A9 was added. When inhibitors
were used, they were introduced at the beginning of the incubation
period. The effect of CO on pHi was also evaluated using CO gas.
Respiration buffer was bubbled with 100% CO gas at 30 °C to obtain a
saturated respiration buffer. Deoxygenated myoglobin (20 μM) was
used as CO scavenger with both CORM-3 and CO gas. To investigate
the interaction between phosphate and BCECF, loaded mitochondria
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−80°C/5min at 30°C) to release BCECF in themedium. A suspension of
broken mitochondria was then introduced in the respiration buffer
containing various concentration of phosphate and BCECF ﬂuorescence
was followed. When inhibitors were used, they were introduced at the
beginning of the incubation period.
2.9. Statistical analysis
The data are reported as mean ± S.E.M. Statistical signiﬁcance
was determined using either Student's two-tailed unpaired t-test or
one-way analysis of variance (ANOVA) followed by Scheffe's post test.
Signiﬁcance was accepted when pb0.05.
3. Results
3.1. CORM-3-mediated uncoupling effect needs phosphate
We previously showed that CORM-3 increased the basal respiration
rate and decreased the mitochondrial membrane potential in isolated
cardiac mitochondria respiring on pyruvate/malate and that these
effectsweremediated by CO. These features are typical of an uncoupling
effect but contrary to classical uncoupling agents we demonstrated that
the effects of CORM-3 were not sudden but occurred slowly over time
[10]. To further investigate the mechanism of this uncoupling effect,
we studied the effect of CORM-3 on pHi using the BCECF method. This4
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Fig. 1. CO inducesmitochondrialmatrix alkalinization. A:Mitochondrial pHiwas studied by follo
each) generated membrane potential and thusmatrix alkalinization. Then (arrow) increasing c
inactive form iCORM-3 (100 μM, line 5), of 20 μM CORM-3 with the CO scavenger deoxymyogl
least 4 independent experiments. Bar graphs represent changes inﬂuorescence between 200 an
introduced in a CO-saturated buffer. Pyruvate/malate (5mM/5mM)was added at the beginnin
were analyzed: respiration buffer (line 1), CO-saturated buffer (line 2), respiration buffer wit
(line 4). Curves are representative of at least 4 independent experiments. Bar graphs represenrepresents an interesting approach to study uncoupling agents as
most of them recycle protons across mitochondrial inner membranes,
disrupting proton gradient and decreasing pHi. As shown in Fig. 1A,
feeding the electron transport chain via complex Iwith pyruvate/malate
increased pHi as the electron transport chain worked and extruded
protons. The uncoupling agent, tyrphostine A9, abolished the gradient
of protons and thus strongly decreased pHi conﬁrming the feasibility
of this method. Surprisingly, CORM-3 did not decrease but rather
increase intra-mitochondrial pHi in a concentration-dependentmanner
which a priori appears counterintuitive for an uncoupling agent. This
effect was also inhibited by deoxy-myoglobin, a scavenger of CO, and
was not reproduced by the depleted or inactive CORM-3 (iCORM-3),
which does not release CO (Fig. 1A). Although to a lesser extent, an
increased pHi was also observed after addition of CO gas conﬁrming
the critical role of CO (Fig. 1B).We observed, however, that the variation
of pHi induced by 20 μM CORM-3 was inhibited in the absence of
phosphate (Fig. 2A). The same effect was observed in the presence
of 1 mM ADP which induces ATP synthesis, leading to phosphate
consumption and matrix acidiﬁcation and, conﬁrming the role of
phosphate in the effect mediated by CORM-3 (Fig. 2A). The data of
Fig. 2 conﬁrm that phosphate greatly contributes to the effect of
CORM-3 as the acceleration of O2 consumption and the decrease in
membrane potential were almost completely inhibitedwhen respiration
was measured in a buffer without phosphate ions (Fig. 2B, C and D). The
next questionwe tried to address was: how can phosphate contribute to
the increased O2 consumption induced by CORM-3? As phosphate is a600
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Fig. 2. CORM-3-mediated uncoupling effect and matrix alkalinization need phosphate. A: BCECF ﬂuorescence was used to evaluate the role of phosphate on mitochondrial alkalinization
induced by CORM-3. After addition of pyruvate/malate (5mM each) that generates membrane potential and thus matrix alkalinization, 20 μM CORM-3 was added in respiration buffer
(line 1), in phosphate-depleted buffer (line 2) or in respiration buffer in the presence of 1mM ADP (line 3). Curves are representative of at least 4 independent experiments. Bar graphs
represent changes in ﬂuorescence between 200 and 800 s. *p b 0.05 vs respiration buffer+ CORM-3 (line 1). B: Membrane potential (Ψm) in isolated heart mitochondria treated with
CORM-3 was followed by measuring the uptake/release of the ﬂuorescent dye rhodamine 123. The following conditions were analyzed: phosphate-depleted buffer (line 1), respiration
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Various conditions were analyzed: respiration buffer (line 1), phosphate-depleted buffer (line 2), respiration buffer with 20 μMCORM-3 in the absence (line 3) or in the presence of 1 μM
cyclosporine A (CsA) (line 5) or 100μMEGTA (line 6), or phosphate-depleted buffer with 20μMCORM-3 (line 4). Each value represents themean±SEM of six independent preparations.
*p b 0.05 vs respective control.
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pore (mPTP) opening [15,16] that induces swelling and increases
respiration, we investigated whether cyclosporine A, a well-known
de-sensitizer of mPTP opening, might inhibit the effects of CORM-3.
Cyclosporine A did not affect the effect of CORM-3 either on O2
consumption, membrane potential or pHi, excluding the possibility
that CORM-3 could act through mPTP opening. The absence of effect of
drugs acting on Ca2+, which is a critical factor for mPTP opening,
reinforced this hypothesis. Indeed, neither the calcium chelator EGTA
(Fig. 2) nor the speciﬁc inhibitor of the mitochondrial Ca2+ uniport
ruthenium red modiﬁed the effect of CORM-3 (data not shown).
3.2. CORM-3 induces phosphate-dependent mitochondrial swelling
Mitochondrial swelling can be induced independently of mPTP
opening. Hence, we examined whether CORM-3 could induce
mitochondrial swelling per se. As depicted in Fig. 3A, CORM-3 induced
swelling in energized mitochondria in a concentration-dependent
manner as attested by the decrease in absorbance. Once again, iCORM-
3 was without effect conﬁrming the direct involvement of CO. In the
same way, cyclosporine A did not inhibit CORM-3-induced swelling
conﬁrming that mPTP opening was not involved in the mechanism.
When phosphate was omitted from the respiration buffer no swellingcould be observed (Fig. 3B). The selective addition of ion to a minimal
sucrose–HEPES buffer validated the crucial role of phosphate. Indeed,
the addition of 5mMof phosphate in the formof potassiumor of sodium
phosphate induced swelling. This was not observed when 5mM KCl or
5 mM NaCl were added to the buffer, excluding a role for potassium,
chloride and sodium when they were alone in the medium (Fig. 3C).
Addition of 1 mM ADP, which as previously mentioned consumes
phosphate, reduced swelling and this was reversed in the presence of
oligomycin (Fig. 3D). In addition, both the rate and the extent of
swelling induced by 20μM CORM-3 were dependent on the amount of
phosphate added (Fig. 3B). Taken together, these data demonstrate
that the entry of phosphate into mitochondria is absolutely necessary
for the effects of CORM-3 but a role for potassium and/or sodium
could not be excluded as phosphate was added under the form of
potassium or of sodium phosphate. Indeed, one can imagine a
mechanism in which phosphate would enter through a phosphate
carrier and either potassium or sodium would enter through a channel
induced by the CORM-3.
Thus, we used a Tris phosphate buffer (phosphoric acid neutralized
with Tris base) that did not contain any of these cations. In this medium
CORM-3 was without effect but this experiment did not allow us to
draw any conclusion as we observed that Tris alone inhibited CORM-
3-induced swelling by an unknown mechanism (data not shown).
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In order to monitor phosphate transport in energized cardiac
mitochondria we developed a technique to measure mitochondrial
phosphate concentration (see Material and methods). Fig. 4A shows
that CORM-3, but not iCORM-3, induces a rapid entry of phosphate into
mitochondria. The maximal effect was observed 1min after addition of
CORM-3 followed by a decrease and then a plateau corresponding
probably to a re-equilibrium of the phosphate concentration. This effect
was concentration-dependent and was observed at concentrations of
CORM-3 that induced the uncoupling and swelling effects.
3.4. Mitochondrial phosphate carriers are involved in the effects mediated
by CORM-3
Phosphate is transported across mitochondrial membranes by two
carriers: 1) the mitochondrial phosphate carrier (PiC), which facilitates
the transport of phosphate together with an equivalent amount of
protons or in exchange for hydroxyl ions and 2) the dicarboxylate
carrier (DIC), which catalyzes the electroneutral exchange of phosphate
with dicarboxylates (malate and succinate). Thus, we investigated
whether these carriers could be involved in the effect mediated by
CORM-3. First, we used high concentrations of the substrate of
DIC malonate which can inhibit malate–phosphate exchange by
saturating the external binding sites of DIC [17]. In these conditions,
malonate reduced bothmitochondrial swelling and increase in intra-
mitochondrial pH induced by CORM-3 (Fig. 5A and B). This change inpH value was also limited by butylmalonate that is considered as a
very effective inhibitor of DIC. Unfortunately, we could not use
butylmalonate in swelling experiments because butylmalonate per se
caused swelling in our experimental conditions. The omission of
pyruvate in the medium, which is necessary for malate entry into
mitochondria via the citrate carrier and for DIC activation [18], or
replacement of malate by glutamate, limited both CORM-3-induced
swelling and increase in intra-mitochondrial pH (Fig. 5A and C). The
effect of CORM-3 persisted when malate was substituted by succinate.
It should be noted that all the experimental conditions that reduced
DIC activity (malonate, changes of substrates) also altered the effect of
CORM-3 on O2 consumption (Fig. 5D). From these results we can
conclude that DIC activity is involved in both CORM-3-induced
phosphate entry into mitochondria and CORM-3-induced swelling.
CORM-3-induced swelling was also inhibited by the thiol reagent
N-ethylmaleimide which is a PiC inhibitor at concentrations that are
ineffective at inhibiting DIC [19] (Fig. 5A). This inhibition was total,
indicating that PiC could be the main target of CORM-3 for phosphate
entry. Importantly, N-ethylmaleimide strongly inhibited phosphate
transport even when a high concentration of CORM-3 was used
(Fig. 4B) and totally suppressed the increase in mitochondrial O2
consumption (Fig. 5D). However, the fact that N-ethylmaleimide also
fully prevented mitochondrial matrix alkalinization (Fig. 5B) was
contradictory as PiC activation leads to co-transport of phosphates and
protons inside mitochondria, and therefore an acidiﬁcation might be
expected. Thus, we suspected a non-speciﬁc effect independent of pH
variations and we speculate that it could result from a competition
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Fig. 4. CORM-3 induces mitochondrial phosphate transport. A: Effect of increasing
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the pKa value for phosphate is slightly higher than that of BCECF
at physiological pH values, 7.2 and 6.97 for phosphate and BCECF,
respectively. In order to investigate this possibility, mitochondria
were loaded with BCECF-AM to generate the ﬂuorescent drug BCECF
and were broken by three cycles of freezing/thawing and BCECF
ﬂuorescence was followed in the presence of increasing concentrations
of phosphate. As shown in Fig. 6, the presence of pyruvate/malate did
not modify BCECF ﬂuorescence (conﬁrming the loss of mitochondrial
integrity) whereas phosphate induced a concentration-dependent
increase in ﬂuorescence. These data demonstrate that in our experi-
mental conditions BCECF and phosphate compete for protons and that
the matrix alkalinization described in Fig. 1 reﬂected in fact phosphate
entry into mitochondria and was not the result of proton exit. Taken
together, these data provide further evidence that the increase in
mitochondrial phosphate is involved in the uncoupling effect of
CORM-3 and that PiC could be responsible for this effect.
3.5. CORM-3 stimulates PiC activity
If PiC is themain target for the induction of swelling by CORM-3, this
effect must be obtained in amodelmonitoring speciﬁcally the transport
of phosphate by PiC. Fig. 7 shows that this is indeed the case. To do this,
we used a swelling assay for phosphate transport in de-energized
mitochondria as previously described [13]. In these experiments, DIC
is inactive and mitochondrial swelling is caused by the entry of
phosphate into mitochondria via PiC. Note that cyclosporine A (1 μM)
was present in themedium to ensure that nomPTP-dependent swelling
occurred following the addition of phosphate. In these conditions,CORM-3, but not iCORM-3, caused a concentration-dependent
activation of mitochondrial swelling. This effect was inhibited in the
presence of several potent PiC inhibitors. In fact, both N-
ethylmaleimide and the sulfhydryl reagent mersalyl [20] suppressed
mitochondrial swelling whereas the more recently described inhibitor
ubiquinone 0 [13] decreased it. This effect was abolished by 1) malate,
which is known to stimulate DIC activity and thus phosphate exit
from mitochondria and 2) glutamate, which is able to co-transport
protons into the mitochondrial matrix. These data show that PiC is
activated by CORM-3.
4. Discussion
CO is produced during the degradation of heme by heme oxygenase
enzymes in mammals and has been suggested to act as an endogenous
signaling molecule in many tissues [21,22]. Although the poisoning
effects of high concentrations of CO that lead to impairment of both
O2 transport by hemoglobin and mitochondrial respiration have been
well described, most of the effects of CO at concentrations that might
reﬂect the amount generated physiologically remain unknown.
Recently, we have shown that lowmicromolar concentrations of CO
are able to regulate oxidative phosphorylation by uncoupling
mitochondrial respiration [10]. In the present paper we demonstrated
that this effect is caused by the activation of PiC that leads to the
increase in intra-mitochondrial phosphate and proton concentrations,
which are both known to play an important role in the uncoupling
effect. As in the previous study, we used the well-characterized water
soluble CO releaser CORM-3 to perform these experiments. The
advantage of this carbonyl complex is its ability to release low and
precise concentrations of CO within the biological milieu. This is not
the case of CO gas that distributes homogeneously in the medium and
can escape into the atmosphere. Moreover, recent studies using
ﬂuorescent probes speciﬁc for CO conﬁrmed that CO-RMs such as
CORM-2 and CORM-3 are more efﬁcient to deliver CO inside the cells
than applying solutions saturated with CO gas [23,24].
We have previously highlighted that malonate, a well-known
inhibitor of complex II, signiﬁcantly reversed CO-mediatedmitochondrial
uncoupling suggesting a possible contribution of complex II in the
uncoupling effect. However, the fact that we did not ﬁnd any change in
the activity of complex II in the presence of increasing concentrations of
CORM-3 [10] leaves open the possibility that additional mechanisms
may take place. Besides to its complex II-inhibiting properties, malonate
is also a substrate of DIC and is able to reduce phosphate transport.
Phosphate being known to be able to induce an increase inmitochondrial
membrane permeability [25,26], a subsequent swelling and thus an
increase in O2 consumption and a decrease in membrane potential, we
focused on the role of phosphate transport on the effects mediated by
CORM-3. Our results demonstrate that phosphate is indeed required
to enable CO to exert its uncoupling effects. Using a method that
directly assesses mitochondrial phosphate concentration, we showed
that CO enhanced the transport of phosphate into mitochondria in a
concentration-dependent manner. This effect was sudden and reached
a maximal effect after 1min, which is concomitant to the fast release of
CO by CORM-3 as previously shown [6]. We also demonstrated that CO
induces a concentration-dependent swelling and this effect also needs
phosphate. Although phosphate is a critical factor for mPTP opening,
the CO-dependent uncoupling of cardiac mitochondria is not caused by
mPTP opening because the effects of CO persist even in the presence of
cyclosporine A, a potent de-sensitizer of mPTP opening.
In mitochondria, phosphate transport is mediated by 2 carriers:
DIC, which exchanges phosphate with dicarboxylate, and PiC, which
co-transports phosphate and protons or exchanges phosphate and
hydroxyl ions [18]. Our results show that PiC might be the target of CO
and DIC may act as a regulator. Indeed, in de-energized conditions
when DIC is inactive and only PiC works, we still observed an effect of
CORM-3 although higher concentrations of the carbonyl complex are
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Fig. 5. Mitochondrial phosphate carriers are involved in CORM-3-mediated effects. A: Mitochondrial swelling induced by 20 μM CORM-3 was followed in the presence of various
substrates: pyruvate/malate 5 mM each (line 1), pyruvate/glutamate 5 mM each (line 2), malate 10 mM (line 3) or succinate 10 mM (line 4). Malonate (20 mM, line 5) and N-
ethylmaleimide (20 μM, line 6) were added at the beginning of the experiments when pyruvate and malate were used as substrates. Curves are representative of at least 4 independent
experiments. Bar graphs represent total swelling amplitude. *p b 0.05 vs pyruvate/malate (line 1). B: The effect of various inhibitors on mitochondrial matrix alkalinization induced by
20 μM CORM-3 was evaluated using the BCECF method. Inhibitors were added at the beginning of the experiment. The following conditions were studied: 20 μM CORM-3 (line 1),
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3), succinate 10mM (line 4) or pyruvate/glutamate 5mM each (line 5). Curves are representative of at least 4 independent experiments. Bar graphs represent changes in ﬂuorescence
between 200 and 800 s. *p b 0.05 vs pyruvate/malate (line 1). D: Substrate-dependent O2 consumption (state 2) was quantiﬁed in isolated heart mitochondria in various conditions:
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207R. Long et al. / Biochimica et Biophysica Acta 1837 (2014) 201–209needed. The total inhibition of CO-mediated effects in the presence of N-
ethylmaleimide at a concentration that speciﬁcally inhibits PiC [19]
conﬁrms these results. However, when DIC is inactivated with speciﬁc
inhibitors or in the absence of dicarboxylate, the effects of CO are highly
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Fig. 6. Changes in BCECF ﬂuorescence reﬂect the competition between BCECF and
phosphate. BCECF ﬂuorescence of a broken-mitochondrial suspension was followed in
the presence of increasing concentrations of phosphate (absence, line 1; 0.5 mM, line 2;
1 mM, line 3; and 5 mM, line 4). Pyruvate and malate (5 mM/5 mM) were added at
300 s to conﬁrm the loss of mitochondrial integrity (line 1). Curves are representative of
at least 4 independent experiments. Bar graphs represent changes in ﬂuorescence
between 0 and 1000 s. *p b 0.05 vs absence of phosphate (line 1).As illustrated in Fig. 8, our results demonstrate that CO activates PiC,
which leads to an increase in intramitochondrial phosphate and
protons. DIC acts as a regulator: when it is working, it exacerbates the
phosphate inﬂux inside mitochondria and thus intensiﬁes the effects
of CO. The increase in intramitochondrial phosphate induces a
subsequent mitochondrial swelling. The increases in swelling and in
proton can both participate to the uncoupling effect induced by CO
but the swelling effect seems to be mainly involved since in conditions
where DIC was not stimulated the uncoupling effect was highly
decreased. We cannot exclude other mechanisms participating to the
uncoupling effect of CO as we previously showed that uncoupling
proteins and adenine nucleotide transporter may be partially involved
[10].
Surprisingly, the data on the effect of CO on intramitochondrial
pHi was not in line with our hypothesis as we observed an increase in
pHi after adding CORM-3 i.e. an extrusion of protons. This could be
explained by the competition between BCECF and phosphate for
protons occurring in our experimental conditions. Indeed, the increase
in ﬂuorescence could be due to the entry of phosphate rather than
the extrusion of protons, conﬁrming the effect of CO on phosphate
transport. This interaction prevents us from concluding about a net
inﬂux of protons inside a mitochondrial matrix. However, with regards
to our results on PiC activity, on phosphate entry inside mitochondria
and on consecutive uncoupling effect, an intramitochondrial increase
in proton concentration is highly likely.
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Fig. 7. CORM-3 stimulates PiC activity. Phosphate transport by PiC was assessed by
swelling assay in de-energized conditions. When present, substrates (glutamate 5 mM
or malate 5 mM) and PiC inhibitors (N-ethylmaleimide 40 μM, mersalyl 40 μM or UQ0
40 μM) were added in the medium before the beginning of the experiment. CORM-3
(80 μM) or its inactive form iCORM-3 was used for these experiments. Swelling was
induced by iCORM-3 (line 1), CORM-3 (line 2), CORM-3 with N-ethylmaleimide (line 3),
CORM-3 with mersalyl (line 4), CORM-3 with ubiquinone 0 (line 5), CORM-3 with
glutamate (line 6) or CORM-3 with malate (line 7). Curves are representative of at least
4 independent experiments. Bar graphs represent total swelling amplitude. *p b 0.05 vs
iCORM-3 (line 1).
208 R. Long et al. / Biochimica et Biophysica Acta 1837 (2014) 201–209Our data clearly involve phosphate transport in the induction of
swelling but they do not exclude a possible involvement of an
electrogenic transport of potassium and/or sodium in this effect. Indeed,
Wilson et al. [27] have recently shown that CORM-3 facilitates the
transport of these cations across bacterial membranes. The mechanism
by which phosphate could induce swelling remains unclear. A possible
role of lipid peroxidation induction at high Pi concentrations [25]
has been proposed. In fact, Pi may stimulate lipid peroxidation leading
to an increase in mitochondrial reactive oxygen species production
and mitochondrial swelling. This phenomenon may participate to the
effect of CORM-3 as we have previously shown that CORM-3 induces
an increase in mitochondrial H2O2 production [10]. Experiments are
in progress to investigate this hypothesis. An important question
emerging from these results is how CO could activate PiC directlyDIC
malate
Pi
malate Pi
Pi
Pi
[Pi]
mitochondrial swell
MRC
activity R
Fig. 8. Scheme summarizing the proposed molecular processes by which CO induces mitochon
phosphate and protons. When pyruvate and malate are used as substrates to energize mitoch
mitochondrial swelling. Bothmitochondrial swelling and the increase in intramitochondrial pro
(Ψm) and an increase in mitochondrial respiratory chain (MRC) activity leading to generatio
transporter (ANT) may also be involved in the uncoupling effect [10].since PiC does not appear to contain any molecular entity able to bind
CO (such as a transition metal or a heme moiety). The activation of PiC
could be due to an indirect interaction through a mediator containing
such a structure. Further investigations are necessary to identify and
characterize such a mediator.
In conclusion, this study demonstrates that CO activates PiC leading
to an increase in phosphate and proton transports inside mitochondria
both of which can contribute to the non-classical uncoupling effect
caused by CORM-3.Acknowledgements
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